Related Experiment Videos
POMB/ACE chemotherapy for mediastinal germ cell tumours
European Journal of Cancer (Oxford, England : 1990)
|May 1, 1997
Summary
Mediastinal germ cell tumors (MGCT) treatment combining POMB/ACE chemotherapy and surgery achieves high remission rates. This effective approach offers promising long-term survival for patients with these rare tumors.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Chemotherapy
Background:
- Mediastinal germ cell tumors (MGCT) are rare malignancies.
- Published data often represent single-institution experiences over extended periods.
Purpose of the Study:
- To evaluate the efficacy of POMB/ACE chemotherapy combined with surgical resection for primary mediastinal germ cell tumors.
- To assess long-term outcomes, including survival and relapse rates, in patients treated with this combined modality.
Main Methods:
- Retrospective analysis of 16 patients with newly diagnosed primary MGCT treated since 1979.
- Treatment involved POMB/ACE chemotherapy followed by elective surgical resection of residual masses.
- Analysis included patients with both non-seminomatous germ cell tumors (NSGCT) and seminomas.
Main Results:
- Complete remission was achieved in 15 out of 16 (94%) patients.
- The 5-year overall survival for NSGCT was 73%.
- No relapses occurred beyond 2 years post-treatment, with a median follow-up of 6.0 years.
Conclusions:
- The combination of POMB/ACE chemotherapy and surgery is an effective management strategy for MGCT.
- This approach yields high complete remission and long-term survival rates for patients with mediastinal germ cell tumors.